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Copyright © 2006 AHC A GFP-labeled sodium-dependent glucose transporter SGLT1 (SGLT-GFP) was transfected
into MDCK cells. SGLT-GFP was localized at the apical membrane in confluent cells. When
cellular cholesterol was depleted by methyl-β-cyclodextrin (MβCD) treatment, the localization
of SGLT-GFP gradually switched from apical to whole plasma membrane. Time-lapse mi-
croscopy revealed that the effect of MβCD appeared within 30 min, and that the transition
of SGLT-GFP to the whole plasma membrane was completed within 2 hr after the adminis-
tration. Immunofluorescence microscopy revealed that the tight junction framework remained
steady during this process. The effect of MβCD on SGLT-GFP localization was counter-
balanced by the addition of cholesterol into the culture medium. Disruption of microtubules
by colcemid also perturbed SGLT-GFP localization. SGLT-GFP localized to the whole plasma
membrane by colcemid treatment, and apical localization was restored within 1 hr after
removal of colcemid. Inhibition of protein synthesis by cycloheximide had no effect on the
transition of SGLT-GFP induced by the MβCD or colcemid. These results indicated that
the apical localization of SGLT-GFP is maintained by cellular cholesterol and microtubules,
possibly with an apical recycling machinery.
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I. Introduction
The sodium-dependent glucose transporter, SGLT1, is
localized at the apical plasma membrane in absorptive epi-
thelial cells of small intestine and proximal tubule cells of
kidney, where it plays pivotal roles in the absorption and
reabsorption of sugars, respectively [14, 16–18, 20, 21].
Localization of SGLT1 to apical membrane is crucial in the
vectorial transport of sugars across the epithelial cell layer.
The mechanism of apical localization of SGLT1 has yet to
be fully elucidated.
It has been reported that SGLT1 associates with deter-
gent-resistant membrane microdomains [10]. Disruption of
these detergent-resistant membrane microdomains by acute
depletion of cellular cholesterol by treatment with methyl-β-
cyclodextrin (MβCD) decreased SGLT1 protein abundance
in these microdomains, and was paralleled by a decrease of
sodium-dependent glucose transport activity. Exposure of
kidney proximal tubule cells to sphingomyelinase, which
depletes both sphingomyelin and cholesterol in plasma
membrane, also decreased glucose transport activity [19].
This effect was counterbalanced by replenishment of
cholesterol with cholesterol-enriched liposomes.
Polarized targeting to the apical plasma membrane of
integral membrane proteins is associated with various intra-
cellular factors. The tight junction separating the apical and
basolateral membrane domains prevents the lateral diffusion
of integral membrane proteins. It has also been reported that
cytoskeletal elements participate in the constitution of
lipid microdomains [1, 5–7, 9], and that microtubules play
an essential role in the trafficking of lipid microdomain-
associated proteins to the apical membrane [4, 12].
To examine whether such intracellular factors, i.e.,
tight junction borders, cholesterol, and microtubules, par-
ticipate in the apical localization of SGLT1, we constructedSuzuki et al. 156
MDCK cells transfected with a GFP-labeled SGLT1 gene
(SGLT-GFP). The localization of SGLT-GFP gradually
switched from apical to whole plasma membrane after
MβCD treatment. Disruption of microtubules by colcemid
also perturbed SGLT-GFP localization. The tight junction
framework remained steady during the course of these
transitions of SGLT-GFP. These data suggest that the
apical localization of SGLT-GFP is maintained by choles-
terol and microtubules, possible with an apical recycling
machinery.
II. Materials and Methods
Construction of SGLT-GFP-expressing MDCK cells
Rat cDNA of SGLT1 was a gift from Dr. M. Kasahara
(Kasahara and Mori, GenBank D16101). To generate the
GFP-labeled SGLT1, a PCR fragment from rat SGLT1
cDNA was inserted into the XhoI-EcoRI sites of pEGFP-N3
vector (BD Biosciences Clontech Japan, Tokyo Japan). The
forward primer includes the XhoI site just before the start
codon of the SGLT1 open reading frame, and the reverse
primer includes the EcoRI site instead of the stop codon.
The DNA sequence was verified with a DNA sequencing.
MDCK cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM; D5796, Sigma-Aldrich Japan,
Tokyo, Japan) supplemented with 10% fetal bovine serum
(FBS), penicillin (100 U/ml), and streptomycin (100 µg/ml)
under an atmosphere of 5% CO2 and air at 37°C. SGLT-
GFP cDNA was transfected into MDCK cells by means of
LipofectAmine Plus transfection reagent (Gibco BRL, Life
Technologies, Tokyo, Japan).
Time-lapse fluorescence microscopy
MDCK cells were cultured on 35-mm glass-based
dishes (Asahi Techno Glass, Tokyo, Japan). The dishes were
set in a culture chamber on the microscope with an atmo-
sphere of 5% CO2 and air at 37°C. Cells were observed
with an inverted fluorescence microscope (IX70, Olympus,
Tokyo, Japan) equipped with a cooled-CCD camera (Cool-
snap fx, Nippon Roper, Chiba, Japan). Images were captured
and processed with IP Lab (Scanalytics, Fairfax, VA, USA).
Ca2+-switch experiment
MDCK cells were cultured confluently on the 35-mm
glass-based dishes and treated overnight (20~24 hr) in Ca2+-
free medium (DMEM without calcium chloride, 21068-028,
Gibco BRL) containing 0.2 mM EDTA, 10% FBS. The
dishes were then mounted in a microculture chamber on
the microscope and observed. During the observation, the
medium was changed to the conventional medium contain-
ing Ca2+.
MβCD treatment
MβCD and water-soluble cholesterol (cholesterol
balanced with MβCD) were purchased from Sigma-Aldrich
(C4555 and C4951). MDCK cells were cultured confluently,
and time-lapse images were captured after the medium
change to the medium containing 15 mM MβCD, or 15 mM
MβCD and 30 µg/ml cholesterol.
Colcemid treatment
Colcemid was purchased from Gibco-BRL (Karyo-
MAX colcemid solution). MDCK cells were cultured con-
fluently. Colcemid (200 ng/ml) was added, and cells were
sampled and fixed for immunofluorescence microscopy.
Immunofluorescence staining and laser confocal microscopy
Anti-peptide antisera were raised in a rabbit or a
guinea pig against rat SGLT1 [15, 16]. Mouse monoclonal
anti-occludin antibody was purchased from Zymed Labo-
ratories (San Francisco, CA, USA). Rat monoclonal anti-
ZO-1 antibody was purchased from Chemicon International
(Temecula, CA, USA). Mouse monoclonal anti-gp135 anti-
body (3F2) was a gift from Dr. G. K. Ojakian [8]. Mouse
monoclonal antibody against chicken α-tubulin was pur-
chased from Sigma-Aldrich. FITC (fluorescein isothiocya-
nate)-conjugated donkey anti-rabbit IgG, FITC-conjugated
donkey anti-guinea pig IgG, LRSC (lissamin rhodamine
sulfonyl chloride)-conjugated donkey anti-rat IgG, Rhoda-
mine Red-X-conjugated donkey anti-rabbit IgG, Rhodamine
Red-X-conjugated donkey anti-mouse IgG were purchased
from Jackson Immunoresearch (West Grove, PA, USA).
Immunofluorescence staining of MDCK cells was carried
out basically as previously described [13, 15]. Specimens
were mounted in an anti-bleaching embedding medium
[11], and observed with an Axioplan 2 fluorescence micro-
scope (Carl Zeiss, Oberkochen, Germany) equipped with an
MRC-1024 laser confocal system (Nippon Bio-Rad Labora-
tories, Tokyo, Japan). Images were captured and processed
with LaserSharp (Bio-Rad) and PhotoShop (Adobe Systems,
San Jose, CA) software.
Measurement of transepithelial electric resistance (TER)
MDCK cells were cultured confluently on the Trans-
well filters (12 mm diameter, Cat. No. 3401; Corning
Coster Japan, Tokyo, Japan). TER was measured using a
Millicell-ERS (Nihon Millipore Ltd., Tokyo, Japan) as
described elsewhere [3]. The TER values were calculated by
subtracting the background values for blank filters and
indicated as percentage of values at t0.
III. Results
Localization of SGLT-GFP during the formation of cell 
polarity
When the cells were cultured confluently, SGLT-GFP
was localized at the apical plasma membrane as seen in wild
type SGLT1 (Fig. 1A) [13]. Since the apical localization
of SGLT1 depends on the formation of the tight junction
framework between the apical and basolateral plasma mem-
branes [13], we first checked the localization of SGLT-GFP
during the course of formation of cell polarity and the tight
junction framework. When MDCK cells whose number was
sufficient for confluent culture were seeded in the Ca2+-freeMaintenance of Apical Localization of SGLT1 157
medium for 24 hr, cells exhibited fibroblast-like shapes and
epithelial cell sheets were not formed (Fig. 1B). SGLT-GFP
was primarily localized to the perinuclear cytoplasmic
compartments (Fig. 1D). When the medium was changed
to Ca2+-containing conventional medium, the cell-to-cell
contact was gradually formed by 30 min after the medium
change. By 2 hr, epithelial sheets were formed (Fig. 1C), and
the tight junction framework was also gradually constructed
(data not shown). After subsequent overnight culture,
polarized epithelial cell sheets were completed. During the
course, the localization of SGLT-GFP gradually changed,
and one hour after the medium change, SGLT-GFP appeared
along the entire plasma membrane (Fig. 1E). By 2 hr, SGLT-
GFP gradually accumulated at the apical membrane (Fig.
1F). When the cells were cultured overnight in conventional
medium after the Ca2+-switch, SGLT-GFP was restricted to
the apical membrane (Fig. 1G).
Effects of MβCD on apical localization of SGLT-GFP
To examine whether cholesterol participates in the api-
cal localization machinery of SGLT-GFP, cellular choles-
terol was completely removed by MβCD treatment. When
the confluent MDCK cells were treated with 15 mM MβCD
for 2 hr, the localization of SGLT-GFP was perturbed and
gradually switched from the apical to the whole plasma
membrane. Immunofluorescence microscopy revealed that
the staining pattern of the tight junction framework
remained steady throughout the course of the transition of
SGLT-GFP localization (Fig. 2A–C). The effect of MβCD
on SGLT-GFP localization was completely counterbalanced
by the addition of cholesterol (30 µg/ml) to the culture
medium (Fig. 2D). These results suggested that the apical
localization of SGLT-GFP is maintained by a system associ-
ated with cellular cholesterol.
Effects of microtubule disruption on apical localization of 
SGLT-GFP
To clarify whether the apical localization of the SGLT-
GFP is associated with the microtubule cytoskeleton,
microtubules were disrupted by colcemid treatment. When
the confluent cells were treated with colcemid (200 ng/ml),
microtubules in the cells were disrupted within 1 hr (Fig.
3A–C). The apical localization of SGLT-GFP, on the other
hand, was maintained at 1 hr (Figs. 3B, 4B). After 2 hr of
colcemid administration, basolateral signals for SGLT-GFP
gradually increased, and SGLT-GFP was localized at whole
plasma membrane by 4 hr (Figs. 3C, 4C). During the course
of transition of SGLT-GFP localization from apical to whole
plasma membrane, the staining pattern of the tight junction
framework was unaffected (Fig. 4A–C). When the colcemid
was washed out with the conventional medium after 4-hr
colcemid treatment, microtubule networks were recon-
structed and reverted to the normal shape by 2 hr (Fig. 3D).
Apical localization of SGLT-GFP was also restored accom-
panied with the reversion of the microtubule networks.
These results suggest that the apical localization of SGLT-
GFP is maintained by the microtubule cytoskeleton.
Fig. 1. (A) Immunofluorescence laser confocal images for SGLT-
GFP (left frames) and ZO-1 (right frames) of confluent MDCK
cells. Projection images of consecutive x-y optical sections are
shown in the upper large panels, and an x-z vertical scanning image
of each upper panel is shown in the lower small panel. (B–G) Dif-
ferential interference-contrast images (B and C) and fluorescence
images of SGLT-GFP (D–G) in MDCK cells in the Ca2+-switch. (B)
Sufficient numbers of the cells for confluent culture were cultured
in the Ca2+-free medium for 24 hr. Cells show fibroblast-like
shape and epithelial junctions are not seen. (C) Two hours after the
medium change, cell-to-cell contact is restored, and polarized epi-
thelial cell sheets are formed. (D) Twenty-four hours in Ca2+-free
medium, SGLT-GFP is primarily localized at the perinuclear cyto-
plasmic region. (E) One hour after the medium change, SGLT-
GFP at the plasma membrane is evident. (F) Two hours after the
medium change, SGLT-GFP is gradually accumulating in the
apical membrane. (G) Eighteen hours after the medium change,
SGLT-GFP is preferentially localized at the apical membrane.
Bars=10 µm.Suzuki et al. 158
Effects of MβCD and colcemid on tight junction function
To examine whether the function of the tight junctions
is influenced by MβCD or colcemid treatment, we examined
TER and the localization of other apical and basolateral
marker proteins. The mean value of TER of the confluent
MDCK cells was 1618±23 Ωcm2. Colcemid treatment did
not affect TER, whereas the MβCD treatment rapidly
reduced the TER of MDCK cells (Fig. 5). Interestingly,
occludin and ZO-1 were localized at the apico-lateral aspect
of the cells and exhibited the typical tight junction frame-
work as seen in control cells either after treatment with
MβCD for 2 hr or colcemid for 4 hr (Fig. 2B–C and Fig. 4B–
C). Moreover, the polarized localization of apical glycopro-
tein gp135 was not affected by either treatment (Fig. 6).
These results suggested that the function for prevention of
lateral diffusion is retained normally during the MβCD treat-
ment for 2 hr or colcemid treatment for 4 hr, and that the
MβCD treatment may only affect the barrier function of
tight junctions.
Basolateral SGLT-GFP is transported from apical aspect of 
plasma membrane
The above results raise a question as to the source of the
basolateral SGLT-GFP, for which there are two possible
answers: one is that the basolateral SGLT-GFP is trans-
ported from the apical plasma membrane domain, and the
other is that the newly synthesized SGLT-GFP protein is
nonspecifically transported to the whole plasma membrane.
To assess these possibilities, de novo protein synthesis was
inhibited by cycloheximide administration during the colce-
mid or MβCD treatment. Administration of cycloheximide
(2 µg/ml) did not affect the transition of apical SGLT-GFP
to whole plasma membrane in colcemid-treated cells (Fig.
4D). Cycloheximide also did not affect the transition of
apical SGLT-GFP to whole plasma membrane by MβCD
treatment (data not shown). These results indicate that the
basolateral SGLT-GFP arises from apical plasma membrane
possibly by a transcytosis-like mechanism accompanied
with the destruction of a system for their apical localization.
IV. Discussion
SGLT-GFP localized at the apical plasma membrane is
dependent on the formation of the tight junction frame-
work as seen in wild type SGLT1 [13]. This observation
indicates that SGLT-GFP is useful as a fluorescent probe for
apical membrane molecules in living MDCK cells. When
the cells were cultured in Ca2+-free medium for 24 hr,
cells could not form intercellular junctions and most of
SGLT-GFP signals were localized in cytoplasmic vesicles
in the perinuclear region. These SGLT-GFP-positive vesicles
started to transfer to the whole plasma membrane 1 hr after
the Ca2+-switch. SGLT-GFP vesicles may be launched to the
whole plasma membrane by a vesicular transport system
that is stimulated by a signal transduction following the
construction of adherence junctions by the Ca2+-switch.
SGLT-GFP signals then gradually accumulated in the api-
cal membrane domain accompanying the formation of the
tight junctions, and preferentially localized at the apical
membrane after subsequent overnight culture. These results
indicate that localization of SGLT-GFP to the apical mem-
brane is dependent on the formation of the tight junction
framework, and that the localization pattern of SGLT-GFP
during the formation of cell polarity is similar to that in
wild type SGLT1.
It has been reported that SGLT1 associates with
detergent-resistant membrane microdomains, and disruption
Fig. 2. Immunofluorescence laser confocal images of MβCD-
treated cells. Projection images of consecutive x-y optical sections
are shown in the upper large panels. An x-z vertical scanning image
of each upper panel is shown in the lower small panel. Green and
red signals indicate the SGLT-GFP and ZO-1, respectively. Arrow-
heads indicate the basolateral SGLT-GFP signals. Bar=10  µm.
Confluent MDCK cells (A) were treated with 15 mM MβCD for
1 hr (B), 2 hr (C), or treated together with MβCD and 30 µg/ml
cholesterol for 2 hr (D). (A) SGLT-GFP is localized at apical
plasma membrane in the confluent cells. (B) One hour after the
MβCD treatment, gradual transition of SGLT-GFP from apical to
whole plasma membrane is seen. (C) Two hours after the treat-
ment, SGLT-GFP is localized along the whole plasma membrane.
The staining pattern of ZO-1 is not affected during the course of
the transition of SGLT-GFP. (D)  Addition  of  cholesterol  com-
pletely counterbalances the effect of MβCD on the localization of
SGLT-GFP.Maintenance of Apical Localization of SGLT1 159
of these microdomains by MβCD decreased the amount of
SGLT1 in detergent-resistant membrane microdomains, a
change that was paralleled by a decrease of sodium-depend-
ent glucose transport activity [10]. These results suggested
that cellular cholesterol may be important for the localiza-
tion of SGLT1. It has been reported that cellular cholesterol
was rapidly depleted from 60% to 50% within 30 min to 2 hr
after treatment with MβCD [2], and that apical targeting of
membrane protein HA associated with lipid raft was per-
turbed [4, 12]. When confluently cultured MDCK cells were
Fig. 3. Immunofluorescence laser confocal images of colcemid-treated cells. Projection images of consecutive x-y optical sections are shown in
the upper large panels. An x-z vertical scanning image of each upper panel is shown in the lower small panel. Green signal indicates SGLT-GFP,
and red signal indicates α-tubulin. Monochrome images show the channel of α-tubulin. Arrowheads indicate the basolateral SGLT-GFP signals.
Bar=10 µm. Confluent MDCK cells (A) were treated with 200 ng/ml colcemid for 1 hr (B), 4 hr (C), treated with colcemid for 4 hr and cultured
in normal medium for 2 hr (D). (A) SGLT-GFP is localized at apical plasma membrane in the confluently grown cells. (B) One hour after
the colcemid treatment. Whereas the microtubule networks are completely disrupted, SGLT-GFP is still localized at apical plasma membrane.
(C) Four hours after the colcemid treatment, SGLT-GFP localizes along the whole plasma membrane. (D) Two hours after the removal of
colcemid, microtubule networks are reconstructed and reverted to normal shape. Apical localization of SGLT-GFP is also restored.
Fig. 4. Immunofluorescence laser confocal images of colcemid-treated cells. Projection images of consecutive x-y optical sections are shown in
the upper large panels. An x-z vertical scanning image of each upper panel is shown in the lower small panel. Green signal indicates SGLT-GFP,
and red signal indicates ZO-1. Arrowheads indicate the basolateral SGLT-GFP signals. Bar=10 µm. Confluent MDCK cells (A) were treated
with 200 ng/ml colcemid for 1 hr (B), 4 hr (C), treated together with colcemid and 2 µg/ml cycloheximide for 4 hr (D). (A–C) The staining
pattern of ZO-1 does not change during the course of transition of SGLT-GFP by colcemid treatment. (D) Four hours after the treatment
with colcemid and cycloheximide, SGLT-GFP is localized along the whole plasma membrane as seen in cells treated with colcemid alone in
panels C.Suzuki et al. 160
treated with MβCD, the localization of SGLT-GFP was per-
turbed and switched from apical to whole plasma membrane.
This response appeared within 30 min, and the transition of
SGLT-GFP to whole plasma membrane was completed by 2
hr. Since the immunofluorescence staining patterns of tight
junction protein ZO-1 and apical marker protein gp135 did
not change during the transition of SGLT-GFP by MβCD
treatment, the change of localization is not due to lateral
diffusion by the destruction of the tight junction borders.
The effect of MβCD for the transition of SGLT-GFP was
completely counterbalanced by the addition of cholesterol.
This result indicated that cellular cholesterol is essential
for apical localization of SGLT-GFP.
Cytoskeletal tracks are essential for the vesicular trans-
port and selective targeting of membrane proteins. Apical
targeting of influenza HA is disrupted accompanied with
destruction of microtubule filaments by nocodazol treatment
[4, 12]. We examined possible involvement of microtubules
in the localization machinery of SGLT-GFP. By 1 hr after
the treatment with colcemid, microtubule networks were
completely disrupted, whereas apical localization of SGLT-
GFP was maintained. Apical localization of SGLT-GFP was
gradually perturbed and SGLT-GFP localized to the whole
plasma membrane by 4 hr. Microtubule networks were
reconstructed and reverted to normal shape within 1 hr after
the removal of colcemid. The apical localization of SGLT-
GFP was concomitantly restored accompanied with the
reversion of the microtubule filaments. Since the immuno-
fluorescence staining patterns of ZO-1 and gp135 did not
change during the transition of SGLT-GFP by colcemid
treatment, it is considered that the transition is not due to
lateral diffusion by the loss of fence function of the tight
junctions. When the cells were treated with colcemid and
cycloheximide, transition of SGLT-GFP to whole plasma
membrane was observed as well. This result indicates that
the basolateral SGLT-GFP originates from that at apical
plasma membrane rather than from a newly synthesized
source. Destruction of microtubules by colcemid treatment
may perturb the apical retention system for SGLT-GFP and
the subsequent transcytosis-like transport of apical SGLT-
GFP to basolateral membrane, resulting in the whole mem-
brane distribution of it.
From these results, we conclude that the apical local-
ization of SGLT-GFP is maintained by cellular cholesterol
and microtubules. Localization of SGLT-GFP to the apical
membrane may be maintained by recycling with continuous
endocytosis and exocytosis, and cholesterol microdomains
and microtubules play important roles in the recycling
machinery.
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